Mecapegfilgrastim for the prophylaxis of chemotherapy‐induced neutropenia in locally advanced nasopharyngeal carcinoma: A prospective phase II clinical study

Documenti analoghi

• Evaluating the reduction of elective radiotherapy fields for de novo metastatic nasopharyngeal carcinoma in the immunotherapy era
  di: Ting Jin, et al.
  Pubblicazione: (2024)
• Loco‐regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real‐world retrospective study from two cancer centers
  di: Li Ma, et al.
  Pubblicazione: (2024)
• A pretreatment multiparametric MRI ‐based radiomics‐clinical machine learning model for predicting radiation‐induced temporal lobe injury in patients with nasopharyngeal carcinoma
  di: Li Wang, et al.
  Pubblicazione: (2024)
• Lachnoclostridium intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma
  di: Zikun Yu, et al.
  Pubblicazione: (2024)
• Higher area deprivation index is associated with poorer local control and overall survival in non‐metastatic nasopharyngeal carcinoma
  di: Nauman H. Malik, et al.
  Pubblicazione: (2024)